Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Targeting the Trabecular Meshwork: Goniotomy Past, Present, and Future

By: Jason Bacharach, MD; Jella An, MD

Webinar Credits: 1.25

This no-fee CME webinar provides valuable information on the efficacy, safety, indications, optimal patient selection, and surgical pearls for microinvasive glaucoma surgery (MIGS).

Expiration Date: Saturday, October 31, 2020
Release Date: October 2019

Learning Objectives

At the completion of this educational activity, the participating ophthalmologist will be better able to:

Identify and understand the advantages and disadvantages of trabecular, supraciliary, and subconjunctival microinvasive glaucoma surgery (MIGS) procedures.

Describe the efficacy and safety of trabecular meshwork (TM) and Schlemm canal MIGS procedures.

Identify the patient characteristics that favor the use of TM and Schlemm canal MIGS procedures.

Adopt optimal surgical techniques when performing TM and Schlemm canal MIGS procedures.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Jason Bacharach, MD

Founding Partner & Director of Research
North Bay Eye Associates Inc.
Sonoma County, California

Co-Director of Glaucoma Division
California Pacific Medical Center
San Francisco, California

Jella An, MD

Medical Director, University Eye Institute East
Director, Glaucoma Service and Fellowship Program
Department of Ophthalmology
University of Missouri
Columbia, Missouri

 

Jason Bacharach, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Glaukos and New World Medical. Speaker’s Bureau: Alcon, Allergan, Glaukos, and New World Medical. Grant/Research Support: Allergan, Glaukos, and Santen.

Jella An, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Iridex, New World Medical. Grant/Research: New World Medical.

 

EDITORIAL SUPPORT
Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests.

Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests.

Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Video Resources

Targeting the Trabecular Meshwork: Goniotomy Past, Present, and Future

By: Jason Bacharach, MD; Jella An, MD

BackNext

Test

Instructions

Step 1 of 2

  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Very confident
  • 1. Never2.3. Neutral4.5. Always
  • AgreeNeutralDisagree
    Identify and understand the advantages and disadvantages of trabecular, supraciliary, and subconjunctival microinvasive glaucoma surgery (MIGS) procedures.
    Describe the efficacy and safety of trabecular and Schlemm canal MIGS procedures.
    Identify the patient characteristics that favor the use of trabecular and Schlemm canal MIGS procedures.
    Adopt optimal surgical techniques when performing trabeular and Schlemm canal MIGS procedures.
Back